Skip to content

13F-HR filed by ACUTA CAPITAL PARTNERS, LLC

ACUTA CAPITAL PARTNERS, LLC filed this 13F-HR for the quarter ended 2014-12-31, filed 2015-02-13, with 64 holding rows worth $147,971,000 by the sum of the rows.

Accession
0001493152-15-000490
Filed
2015-02-13
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2014

A holdings report, 64 entries on the cover page, a total value of $147,971,000,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $147,971,000 with VALUE read as thousands by filing date, 13F file number 028-16527. The quarter's positions are built on this report. The resolved quarter.

The cover page states a total of $147,971,000,000, about 1,000 times the sum of the rows, $147,971,000. The filer likely wrote its cover total in dollars and its rows in thousands. This page uses the sum of the rows.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
iShares Russell 2000 ETF464287655SHS230,000$27,513,000thousands by filing dateput
AMICUS THERAPEUTICS INC03152W109COM1,632,720$13,584,000thousands by filing date
PowerShares QQQ Trust Unit Ser73935A104COM70,000$7,228,000thousands by filing dateput
ALIMERA SCIENCES INC016259103COM1,056,809$5,855,000thousands by filing date
PERNIX THERAPEUTICS HOLDINGS71426V108COM604,075$5,672,000thousands by filing date
BIOTELEMETRY INC090672106COM483,872$4,853,000thousands by filing date
CEMPRA INC15130J109COM164,800$3,874,000thousands by filing datecall
EXELIXIS INC30161QAC8NOTE 4.250% 8/16,474,000$3,613,000thousands by filing dateprincipal
LEMAITRE VASCULAR INC525558201COM463,000$3,542,000thousands by filing date
ZAFGEN INC98885E103COM100,263$3,092,000thousands by filing date
TETRAPHASE PHARMACEUTICALS INC88165N105COMMON STOCK74,803$2,970,000thousands by filing date
CTI BIOPHARMA CORP COM NEW12648L106Stock1,228,111$2,898,000thousands by filing date
RRSAT GLOBAL COMM NTWRK LTDM8183P102SHS401,424$2,890,000thousands by filing date
CARDIOME PHARMA CORP14159U301COM NO PAR303,477$2,807,000thousands by filing date
VOLCANO CORPORATION928645100COM153,436$2,743,000thousands by filing date
IGNYTA INC451731103COM369,360$2,530,000thousands by filing date
Vertex Pharmaceuticals Incorporated92532F100COM20,000$2,376,000thousands by filing datecall
RECEPTOS, INC.756207106COMMON STOCK18,768$2,299,000thousands by filing date
ENANTA PHARMACEUTICALS INC29251M106COM44,528$2,264,000thousands by filing date
HORIZON PHARMA PLCG4617B105SHS167,491$2,159,000thousands by filing date
VASCULAR SOLUTIONS INC92231M109COMMON STOCK74,494$2,023,000thousands by filing date
ORTHOFIX INTL N VN6748L102COM67,058$2,016,000thousands by filing date
CERUS CORP157085101COM308,282$1,924,000thousands by filing date
IRIDEX CORP462684101COM208,933$1,797,000thousands by filing date
BUILD-A-BEAR WORKSHOP INC120076104COM88,740$1,784,000thousands by filing date
EHEALTH INC28238P109COM69,519$1,732,000thousands by filing date
PAPA MURPHYS HLDGS INC698814100COM140,462$1,632,000thousands by filing date
Ocugen43358V109Common136,804$1,505,000thousands by filing date
DEPOMED INC249908104COM90,958$1,465,000thousands by filing date
HYPERION THERAPEUTICS INC44915N101COM60,462$1,451,000thousands by filing date
GW PHARMACEUTICALS PLC36197T103ADS20,000$1,354,000thousands by filing datecall
KINDRED BIOSCIENCES INC COM494577109Stock171,807$1,280,000thousands by filing date
FORWARD PHARMA A/S34986J105SPONSORED ADR60,730$1,265,000thousands by filing date
CERUS CORP157085101COM200,000$1,248,000thousands by filing datecall
ARRAY BIOPHARMA INC04269XAA3NOTE 3.000% 6/01,315,000$1,229,000thousands by filing dateprincipal
AMAG PHARMACEUTICALS INC00163U106COM26,596$1,134,000thousands by filing date
PARATEK PHARMACEUTICALS INC699374302Equity29,252$1,128,000thousands by filing date
COMBIMATRIX CORPORATION20009T303COM NEW853,278$1,101,000thousands by filing date
HORSEHEAD HLDG CORP440694305COM68,577$1,086,000thousands by filing date
AGENUS INC00847G705COM NEW268,466$1,066,000thousands by filing date
BELLICUM PHARMACEUTICALS INC079481107COM45,750$1,054,000thousands by filing date
MOL GLOBAL INC60845Q105Depository Receipt339,575$1,036,000thousands by filing date
CARDICA INC14141R101COM1,465,905$1,026,000thousands by filing date
HERON THERAPEUTICS INC427746102COM101,050$1,017,000thousands by filing date
Innocoll45780Q103SPONDS ADR164,108$974,000thousands by filing date
CEMPRA INC15130J109COM40,000$940,000thousands by filing dateput
CAS MED SYS INC124769209COM522,467$862,000thousands by filing date
GENVEC INC NEW37246C307cs354,784$738,000thousands by filing date
ATHENAHEALTH INC04685W103COMMON STOCK5,000$729,000thousands by filing dateput
NEUROCRINE BIOSCIENCES INC64125C109COM31,500$704,000thousands by filing datecall
ANTARES PHARMA INC036642106COM232,762$598,000thousands by filing date
SEQUENOM INC COM NEW817337405COM155,135$574,000thousands by filing date
NANOSPHERE INC63009F105COM1,456,884$571,000thousands by filing date
CHEMBIO DIAGNOSTICS163572209COM146,099$571,000thousands by filing date
PSIVIDA CORP74440J101COM122,338$503,000thousands by filing date
NPS PHARMACEUTICALS INC62936P103COM10,000$358,000thousands by filing datecall
XENCOR INC98401F105COMMON STOCK22,011$353,000thousands by filing date
OXFORD INDS INC691497309COM24,742$337,000thousands by filing date
NPS PHARMACEUTICALS INC62936P103COM8,000$286,000thousands by filing date
VERACYTE INC COM92337F107Stock29,024$280,000thousands by filing date
INSMED INC COM PAR $.01457669307Stock13,154$203,000thousands by filing date
TRILLIUM THERAPEUTICS INC COM NEW89620X506Stock19,000$171,000thousands by filing date
COMMUNITY HEALTH SYS INC NEW203668116RIGHT 99/99/99992,963,721$74,000thousands by filing date
ASSEMBLY BIOSCIENCES INC045396108COM3,800$30,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001493152-15-000490this filing2015-02-13acceptance time not in the bulk data set